2026 Breakthrough T1D Fellowship Awardees
Alessandro Fierro
Breakthrough T1D 2026 Awardee - Awarded at the 25t ISPAD Science School for Physicians
Alessandro Fierro
Breakthrough T1D 2026 Awardee - Awarded at the 25t ISPAD Science School for Physicians
Dr Alessandro Fierro is a paediatrician whose clinical and research career is dedicated to paediatric diabetes, with a particular focus on the early stages of type 1 diabetes (T1D) in children and adolescents, ranging from screening and prevention to immune mechanisms and glycaemic control.
His academic career began at the University of Naples Federico II, where he completed a five-year specialisation in Paediatrics at the Department of Translational Medical Sciences – Paediatrics, receiving extensive training in clinical care and research in paediatric diabetes. During this period, he was mentored by Prof. Enza Mozzillo, under whose guidance he developed his clinical and research expertise in this field.
In 2025, he undertook a six-month honorary research fellowship in paediatric diabetes at the Department of Paediatrics, School of Clinical Medicine, University of Cambridge, United Kingdom, under the supervision of Prof. Maria Loredana Marcovecchio. During this time, he worked within an internationally renowned research environment, taking part in clinical and research activities and attending meetings of the East Anglian Paediatric Endocrine Group, which further strengthened his expertise in paediatric diabetes and his international scientific collaborations.
His external training also includes the ISPAD Science School for Physicians in Aydฤฑn, Türkiye, in 2026. He is author and co-author of peer-reviewed publications, a book chapter, and conference presentations on T1D; he has contributed as an expert reviewer to national clinical practice recommendations. He collaborates with the Italian paediatric diabetes research community through the Italian Society for Paediatric Endocrinology and Diabetes (ISPED) Diabetes Study Group.
His research interests focus on the immune mechanisms underlying the progression of T1D and their relationship with glycaemic control. Building on his previous findings, he intends to conduct a prospective study at the University of Naples Federico II to identify immune biomarkers that could support future immunotherapy strategies for T1D.
Anna Pham-Short
Breakthrough T1D 2026 Awardee
Anna Pham-Short
Breakthrough T1D 2026 Awardee
Dr Anna Pham-Short is a Senior Paediatric Diabetes Dietitian and Clinician Researcher at The Children's Hospital at Westmead, Sydney, Australia. For more than 18 years she has walked alongside children, young people and their families living with type 1 diabetes (T1D), helping them fit diabetes cares into the realities of everyday life, food and culture.
Anna's PhD through the University of Sydney (2019) explored the impact of coexisting coeliac disease (CD) on T1D in children and adolescents. Her work spanned a systematic review of CD screening and studies of quality of life, glycaemic variability, nutritional quality, bone health and microvascular complications, along with a focus on what living with two chronic conditions involving dietary management means for young people. It led to six first-author publications in journals including Diabetes Care, and the Journal of Pediatrics, which also helped inform clinical guidelines, and was complimented with presentations at ISPAD, ANZSPED and ADA.
Clinically, Anna sees every day how closely food, emotions and diabetes are intertwined. This inspired her current research into disordered eating in youth living with T1D, who face a markedly higher risk than their peers. She is a co-author of a systematic review and meta-analysis of the prevalence of eating disorders and disordered eating in children and young people living with T1D.
Through the ISPAD-Breakthrough T1D Research Fellowship, Anna will lead "Nourishing Confidence", which embeds routine screening for disordered eating, dietary quality and food insecurity into paediatric diabetes care, and evaluates the Diabetes Body Project with culturally and linguistically diverse (CALD) young people, living in Western Sydney - which is one of Australia's most diverse areas, yet disordered eating in CALD communities remains largely unstudied in Australia.
Inclusive, culturally responsive care is also at the heart of Anna's work. She has co-authored ISPAD and Life for a Child carbohydrate counting resources for India, Mexico, Ecuador and Pakistan, and has taught at an ISPAD postgraduate course in Vietnam. She hopes her work will help young people with diabetes nourish both their health and their confidence.
Bhanu Nalluri
Breakthrough T1D 2026 Awardee
Bhanu Nalluri
Breakthrough T1D 2026 Awardee
Dr. Bhanu Teja Nalluri is a DM resident in Department of Endocrinology, Diabetes and Metabolism at Osmania Medical College and Hospital, Hyderabad, India. He earned his MBBS from Gandhi Medical College and his MD in General Medicine from Nizam's Institute of Medical Sciences, both in Hyderabad. At Osmania, a high-volume public tertiary center, he cares for many children and young adults with type 1 diabetes (T1D), and this experience shapes his research focus.
His DM thesis examined the genetic and immunological risk architecture of T1D in South Indian patients. Using microarray-based high-resolution HLA typing and non-HLA genotyping, he showed that the genetic basis of T1D in India differs substantially from the European pattern, in both HLA and non-HLA risk. These differences were associated with autoimmune comorbidities, the honeymoon period and the risk of DKA at onset, and they indicate that European-derived genetic risk scores need recalibration for Indian populations. The work was carried out in collaboration with CSIR-CCMB and funded by the Endocrine Society of India.
As a 2026 ISPAD–Breakthrough T1D Research Fellow, Dr. Nalluri will build on this foundation under the supervision of Prof. Rakesh Kumar Sahay and Prof. Neelaveni Kudugunti. In a larger cohort, he will further characterize HLA and non-HLA genetic risk in Indian T1D and examine how these variants relate to autoimmunity and clinical presentation, with the aim of developing an Indian-specific genetic risk score.
His wider research includes the psychosocial impact of T1D in schoolchildren, adjunctive metformin and acarbose therapy, and cardiovascular autonomic dysfunction in paediatric T1D, as well as other paediatric endocrine and metabolic disorders. He has published in Hormone Research in Paediatrics, Neuroendocrinology, Indian Journal of Pediatrics and JCEM Case Reports, and has presented at ESE-ESPE 2025 and several national meetings.
He is a member of ISPAD and several endocrine societies. His long-term goal is to establish a sustainable, translational T1D research programme in India. He aims to build large, deeply phenotyped cohorts and validate genetic risk scores and immune markers tailored to South Asian populations, bringing them into routine public hospital care for earlier detection and targeted screening. Above all, he is committed to better care for children with T1D and stronger support for the families who look after them, so that type 1 diabetes never stands between a child and their dreams.
Ingrida Stankute
Breakthrough T1D 2026 Awardee
Ingrida Stankute
Breakthrough T1D 2026 Awardee
Dr. Ingrida Stankute, MD, PhD, is a paediatric endocrinologist, researcher, and associate professor at Lithuanian University of Health Sciences (LUHS) and Kaunas Clinics. She is Head of the Laboratory of Diabetes at the Institute of Endocrinology, LUHS, and works clinically with children and adolescents with diabetes and other endocrine disorders.
Dr. Stankute’s research focuses particularly on type 1 diabetes (T1D), monogenic diabetes (MD), pancreatic β-cell function, diabetes genetics, and precision medicine. Her PhD research investigated the prevalence, β-cell function, and genetic background of MD in young people. She is actively involved in national and international research collaborations addressing the epidemiology, early detection, prevention, and personalised management of diabetes in children and adolescents.
Alongside her research activities, Dr. Stankute has a strong interest in supporting young people with T1D throughout different stages of care, including the transition from paediatric to adult healthcare. Her work combines clinical practice, research, and education, with a particular emphasis on improving long-term outcomes and quality of care for children and young people living with diabetes.
Her ISPAD Breakthrough T1D project focuses on the early identification of children at increased risk of T1D by combining islet autoantibody screening with genetic risk stratification. The project aims to serve as a first step towards implementing broader population-based T1D screening in Lithuania, a country with one of the highest rates of childhood T1D in Europe, facilitating earlier diagnosis and creating opportunities for future prevention strategies.
Rachel Flanagan ๐
Breakthrough T1D 2026 Awardee - Awarded at 21st ISPAD Science School for Healthcare Professionals
Rachel Flanagan ๐
Breakthrough T1D 2026 Awardee - Awarded at 21st ISPAD Science School for Healthcare Professionals
- Download and read the progress report here.
- Dr. Rachel Flanagan is a graduate of the Doctorate in Counselling Psychology at Trinity College Dublin. She is now a Senior Counselling Psychologist working in Paediatric Diabetes and Paediatric Obesity at Children’s Health Ireland (CHI). In this setting, Dr Flanagan has focused particularly on the use of therapeutic models such as Acceptance and Commitment Therapy (ACT) and Compassion Focused Therapy (CFT) to support young people living with a medical condition. Dr Flanagan co-facilitates a multidisciplinary psychoeducational group for older teenagers with Type 1 Diabetes (T1D) transitioning to adult care and this is part of an ongoing research study at CHI for which she is a co-investigator. She is now aiming to research an ACT based intervention for younger adolescents living with T1D who are making the significant transition to secondary school.
Tiago Jeronimo Dos Santos
Breakthrough T1D 2026 Awardee
Tiago Jeronimo Dos Santos
Breakthrough T1D 2026 Awardee
Tiago Jeronimo Dos Santos, MD, MPH, PhD, is a pediatric endocrinologist and clinician-scientist based in Almería, Andalusia, Spain. He is an Assistant Professor of Medicine at the University of Almería and a Pediatric Endocrinology Consultant at “Instituto Hispalense de Pediatría”. He completed his medical and pediatric endocrinology training in Brazil, followed by postgraduate training in Spain, including a Master and PhD in Epidemiology and Public Health from “Universidad Autónoma de Madrid”, Spain. His international training has also included fellowships and research experiences in the United States, as a recipient of the Allan Drash Clinical Fellowship, and Poland.
His research focuses on type 1 diabetes in children and adolescents, with particular interests in diabetes technologies, implementation science, health equity, and, more recently, early detection and prevention of type 1 diabetes. He has contributed to international collaborative studies, systematic reviews, and clinical practice guidelines addressing diabetes technologies, access to care, exercise, and pediatric diabetes management.
He has been actively involved in the ISPAD, including service on its Advisory Board, and previous leadership within the JENIOUS group for young investigators. He is also involved in the European Society for Paediatric Endocrinology (ESPE) and several Spanish and Latin American societies.
He currently leads “PREPARA-T1D Andalucía”, a pilot program evaluating the feasibility and acceptability of population-based screening for presymptomatic type 1 diabetes within pediatric primary care in Southern Spain. His long-term research goal is to help translate advances in type 1 diabetes screening and prevention into equitable, sustainable healthcare strategies for children and families.
Tim Hropot
Breakthrough T1D 2026 Awardee
Tim Hropot
Breakthrough T1D 2026 Awardee
Tim Hropot graduated from the Faculty of Medicine, University of Ljubljana, in 2022. During his medical studies, he became actively involved in pediatric diabetes research. He has continued this work throughout his pediatric residency and PhD research at the Pediatric Clinic of the University Medical Centre Ljubljana, one of the leading centres for pediatric diabetes care in the region. He was one of the participans at the ISPAD Science School for Physicians
in Hannover, Germany in 2025.
His research focuses on diabetes in children and adolescents, particularly how well modern diabetes technologies work, including automated insulind delivery systems and continuous glucose monitoring. He studies clinical outcomes, how treatment can be optimized, and how advanced technologies perform in routine pediatric care outside controlled trial settings. A distinctive part of his work is quantitative analysis of CGM data. He combines clinical expertise with data science and statistical methods to make use of the large, high-frequency datasets that modern diabetes devices produce.
In clinical practice, he manages children and adolescents with type 1 diabetes. This includes starting and following up insulin pump therapy and technology-supported treatment, as well as interpreting device data to guide individual treatment decisions. He is also involved in educating patients and caregivers, helping families use modern diabetes devices safely and confidently in daily life, from school and sports to sleep and illness management.
He is the author and co-author of several scientific publications in pediatric diabetes. His main interest is translating research findings into better patient care, with the aim of making data๏ฟพdriven, technology-supported diabetes management available and effective for every child.
Xinyi Xu ๐
Breakthrough T1D 2026 Awardee - Awarded at 21st ISPAD Science School for Healthcare Professionals
Xinyi Xu ๐
Breakthrough T1D 2026 Awardee - Awarded at 21st ISPAD Science School for Healthcare Professionals
- Download and read the progress report here.
Xinyi is a registered dietitian and CDCES currently practicing in the Pediatric Endocrinology Division at Montefiore Hospital. She obtained her BS at New York University and her MS at Columbia University. She was engaged in research at NYU Langone on mobile health interventions for Chinese immigrants with T2D, prompting her to adapt the DPP into culturally tailored educational videos. At Montefiore, she focuses on investigating Hispanic caregivers' perceptions of nutrition in managing type 1 diabetes, while identifying systemic barriers to effective diabetes care. Dedicated to health equity, Xinyi develops culturally appropriate strategies to improve diabetes outcomes for underserved populations.